Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2890457 in Healthy Volunteers and Type 2 Diabetes
NCT01725126Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2013
- Primary completion
- Sep 2013
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GSK2890457 in type 2 diabetes mellitus (T2DM), obesity, sponsored by GSK. Started Feb 2013; status: completed.
02
Drugs
GSK2890457
03
Conditions
type 2 diabetes mellitus (T2DM)obesity
Beyond the preview
Go deeper on NCT01725126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01725126.